RGTARGENT BIOPHARMA LIMITEDMarket sensitive

RGT Executes Global CannEpil Licensing Deal for US$5.5M

Date and time
Announcement type
Company Update
Show details
Category
Other
Report codes
11001
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences
View on ASXOpen original PDFRGT announcement history

Recent RGT announcements